|
|
|
| |
|
|
|
|
|
Pelvic inflammatory disease (PID) |
|
| Alternative Names: | PID; Oophoritis; Salpingitis; Salpingo-oophoritis; Salpingo-peritonitis
|
| Treatment: | Early diagnosis of mild PID may be treated on an outpatient basis with antibiotics and close follow-up.
More complicated cases or those involving widespread or well-established infection may require inpatient care (hospitalization). Intravenous antibiotics are used, and usually followed with a course of oral antibiotics. Surgery may be considered for complicated, persistent cases that do not respond to adequate antibiotic treatment. Concurrent treatment of sexual partner(s) and the use of condoms throughout the course of treatment are essential.
|
| Expectations (prognosis): | In 15% of cases, the initial antibiotic therapy fails, and 20% experience a recurrence of PID at some time during the reproductive years.
|
| Complications: | The risk for ectopic pregnancy increases from 1 in 200 to 1 in 20 after having PID.
Infertility risks also increase:
- 15% risk of infertility following the 1st episode of PID
- 30% risk of infertility following 2 episodes of PID
- 50% risk of infertility following 3 or more episodes of PID
|
| Calling your health care provider: | Call your health care provider if symptoms of PID occur. Also call if you suspect that you have been exposed to a sexually transmitted disease or if treatment of a current STD does not seem to be effective.
|
|
|
Review Date: 7/24/2002
Reviewed By: Peter Chen, M.D., Department of Obstetrics & Gynecology, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
|
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
|
|
